Find an expert

Professor Jason Ferris, is the Director of Research and Statistical Support Services (RASSS), University of Queensland. While providing service primarily to the Faculty of Medicine the service is expanding to support other organisation units. He is also a leading research academic at the Centre for Health Services Research (CHSR) where he is the Program Leader for Global Substance Use and Mental Health (GSUMH) unit. He holds an honorary professorial role at Turning Point, Victoria (2018-) and is also the Chief Data Scientist for the Global Drug Survey (2013-). Since 2019 he has held a ministerial appointment as an Advisory Council Member to the Queensland Mental Health Commission and is an interRAI Fellow (interrai.org).

Since 2020, Professor Jason Ferris, in collaboration with Dr Dom Gorse (Director of QCIF Data Science) and many others across QCIF and UQ, have been working on the development and deployment of UQ KeyPoint - an innovative data infrastructure, data governance and digital solution enabling researchers to access, manage, analyse and share sensitive research data in a scalable, fully governed and highly secure environment. The work has received a number of accolades. In 2023, The University of Queensland recognised the value of KeyPoint winning the Award for Excellence in Innovation. In 2022, the Faculty of Medicine recognised his commitment and leadership to the University awarding him and the team the Innovators of the Year Award. Professor Ferris has received other recognition as well. In 2021, the Faculty of Medicine recognised the outstanding support of RASSS with a Service Excellence Award. In 2020, The University of Queensland recognised his contributions to his research field: he was awarded the Faculty of Medicine Leader of the Future Award (Academic) and The Director's Choice Award for contributions to the Centre for Health Services Research. In 2019, he was awarded The Outstanding Mid-Career Researcher within the Centre for Health Services Research and was also chosen as a finalist for the Faculty of Medicine Leader of the Future Award (Academic). Additionally, across the Faculty of Medicine, his Research and Statistical Support Service, was nominated for a Service Excellence Award (2019 and 2020). In 2015, he received the University of Queensland, Early Career Researcher Award within the Faculty of Humanities and Social Science. In September, 2014, he received a Highly Commended Early Career Researcher Award within the Faculty of Humanities and Social Science.

He has been involved in a number of key projects: The Queensland Evaluation of the Alcohol Fuelled Violence Policy (QUANTEM), The Overarching Evaluation of the National Support for Child and Youth Mental Health Program (CHYME), the evaluation of ProjectSTOP (a decision-making national database for pharmacists aimed at preventing the use of pseudoephedrine based products as a precursor in the manufacture of methamphetamine), and a national review of the links between random breath testing and alcohol-related road traffic accidents. Jason has over 20 years of social science and public health research experience. He has a well-established publication record with a strong focus on alcohol and drug research and public health. With a Master degree in biostatistics he has well developed and expansive quantitative methods skills and a broad range of experience in many of the facets of both social science and medical research. In 2014 his PhD on alcohol epidemiology was conferred.

Previously, as a senior statistician at the Institute for Social Science Research he developed and taught a number of training models in research methods and statistical analysis as part of the Methods for Social Analysis and Statistics (MFSAS). Since its inception in 2012 he has been course coordinator and trainer for a number of these training modules (see below). From 2016-2018 he was the Director of MFSAS. Between 2016-2017 he was also the ISSR Co-postgraduate Coordinator.

I am a physician at RBWH where I did my undergraduate training. I subspecialised in THoracic Medicine with a focus on bronchoscopy. I helped to create a large interventional service here. Part of that inlcuded instituting endobronchial ultrasound ( EBUS), an Australian first, in 2003. This has become standard of care for diagnosing lung cancer.

My research has been centred on how specimens from EBUS can be optimised. I have had strong collaboration with UQCCR, Pathology Queensland and QIMR Berghofer. Our work has expanded on 2 fronts- 1. use of simple cytology smears as the source for panel molecular testing and 2. The expanded role of WES and WGS on these samples.

We have instituted a large Australia wide collaborative network who are collecting samples along with us( The Debutant studies).We have Cancer Council Australia / CCQ/ and NHMRC grants fr these studies

I am a public health sociologist with research interests in the health and wellbeing of people experiencing marginalisation and the social determinants of (sexual) health. I am the course coordinator of PUBH7033 Foundations of Public Health and PUBH7003 Qualitative Research Methods. I am engaged in social research projects related to HIV, sexual health, young people, LGBTIQ+ health, sex worker health and the scholarship of teaching and learning.

Dr Fleming is an occupational therapist and researcher in the field of brain injury rehabilitation. Her PhD completed in 1996 was on the topic of the development of self-awareness following traumatic brain injury. She has continued to pursue collaborative research on role of metacognitive factors in brain injury rehabilitation. Other research interests include prospective memory assessment and rehabilitation, community integration and the transition from hospital to the community, and psychosocial adjustment and outcomes following acquired brain injury, as well as lifetime care and support for people with complex neurological disability. She is Professor of Occupational Therapy at The University of Queensland, and is a Fellow of the Occupational Therapy Australia Research Academy, member of the American Occupational Therapy Research Academy, a Fellow of the Australasian Society for the Study of Brain Impairment, and Co-Editor of Brain Impairment.

Professor Vicki Flenady is the Director of the Centre of Research Excellence in Stillbirth (Stillbirth CRE), based at Mater Research – The University of Queensland. She is a nationally and internationally renowned clinical perinatal epidemiologist with specific expertise in stillbirth.

Professor Flenady has over 150 publications (including more than 30 Cochrane systematic reviews) with more than 50 in the last five years. She has also authored four book chapters and numerous state-wide and hospital clinical outcome reports. She led two papers in The Lancet Stillbirths Series in 2011 (one an accompanying research paper) and co-authored all others as a member of the series steering committee overseeing the production and dissemination of the series of six papers, two supplemental papers, and five commentaries. She is a member of the Study Group for The Lancet’s 2016 Ending Preventable Stillbirths series, leading one paper and co-authoring all others (five in total). Other key research publications as lead/senior author include a suite of papers on the development of global indicators for maternity and newborn care and evaluation of classification systems for the development of a new WHO classification system for stillbirth and neonatal death. She has also authored or co-authored books and developed many national and state guidelines pertaining to stillbirth and neonatal death.

Professor Flenady's successful bid to establish Australia's first Stillbirth CRE has formally brought together parents, parent advocates, health care professionals, researchers, professional colleges, and policy makers, to reduce stillbirths and improve the quality care for women and families after stillbirth. A collaboration of academic institutions and not-for-profit organisation, The Stillbirth CRE is an Australia-wide initiative aiming to reduce the rate of stillbirthin Australia and ensure quality, respectful care for all families who experience the tragedy of stillbirth.

Professor Flenady is currently leading two NHMRC funded studies; a large-scale cluster randomised controlled trial testing the role of a mobile phone app for women on decreased fetal movements in reducing stillbirth, and a multisite study to identify causes of stillbirth and the value of recommended investigations for stillbirth. Through the Perinatal Society of Australia and New Zealand (PSANZ), Vicki leads a collaboration promoting best practice in perinatal mortality through bi-national guidelines and clinician education with a major focus on investigation into the causes of stillbirth and bereavement care.

Professor Flenady has won a number of awards including: the 2008 National Institute of Clinical Studies evidence into practice award for implementing the Perinatal Society of Australia and New Zealand Perinatal Mortality Audit Guidelines; the 2011 Eileen Potter Award for Translating Research Into Practice; the 2016 Excellence in Research Award Mater Medical Research institute; the 2013 the Medal of Distinction Women’s Healthcare Australasia honouring her outstanding contribution at a national level to improving health of women through service provision, leadership and advocacy; and the 2018 Distinguished researcher award from the International Stillbirth Alliance.

Kwun is a Thoracic and Sleep Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre (UQTRC). His research interests are focussed on making and translating research discoveries to improving outcomes and the health of people who are affected by lung disease particularly lung cancer screening/early detection and biomarkers. The UQTRC is also passionate at enabling productive collaborations to maximise research impact and scale with contributions to The Cancer Genome Atlas Project, Pan-Cancer Analysis of Whole Genomes (PCAWG), IASLC Lung Cancer Staging Project and others.

Pauline Ford is Deputy Provost at The University of Queensland. She was previously Head, School of Dentistry, becoming the first woman to lead a School of Dentistry in the Australia New Zealand region. Pauline graduated from The University of Queensland in 1989 with BDSc (Hons) (University Medal). After nine years in general dental practice, she returned to UQ and undertook a PhD before joining the academic staff in 2005. She has since completed a Graduate Certificate in Higher Education and a Masters in Public Health.

Dr Kathryn Fortnum is a Research Fellow at the Health and Wellbeing Centre for Research Innovation, a collaboration between the School of Human Movement and Nutrition Sciences at the University of Queensland, and Health and Wellbeing Queensland. Her research speciality is on the role of physical activity in the management of chronic health conditions. Dr Fortnum is an Accredited Exercise Physiologist and has a particular interest in children and youth, and mental health. Dr Fortnum has worked clinically in inpatient and community settings for the Child and Adolescent Mental Health Service WA, and supported children impacted by neurological disorders including spina bifida and cerebral palsy to engage in community-based physical programs.

Carl (Saibai Koedal) is a PhD Candidate studying the epidemiology of rheumatic heart disease in Queensland using linked hospital and administrative data. Currently, Carl holds an academic appointment (Lecturer, Physiotherapy) in the School of Health and Rehabilitation Sciences, the University of Queensland, and maintains a clinical role as a Staff Physiotherapist at The Prince Charles Hospital. Alongside research, Carl is also working to strengthen relationships between remote Torres Strait Islander communities and UQ to explore opportunities for education, student clinical placement and research partnerships.

Dr Cathy Franklin is passionate about improving the health of people with intellectual disability and those on the autism spectrum. Cathy is a psychiatrist who has specialised in the psychiatry of intellectual disability and autism in adolescents and adults since 2004. Her career focussed on clinical work and education until 2015, when she commenced a part-time research appointment, in addition to her clinical work. Cathy is the inaugural Director of the Mater Intellectual Disability and Autism Service (MIDAS), a state-wide clinical service established in 2018 that works to improve the health and mental health of adults with intellectual disability and those on the autism spectrum. Cathy is also Director of QCIDD, the Queensland Centre for Intellectual and Developmental Disability, a centre established in 1997 by Professor Nick Lennox, and best known for its many contributions to health of people with intellectual disability, including the CHAP health assessment tool and the AbleX massive open-online course that Cathy contributed mental health content to.

Cathy's research interests include health services research and the biological underpinnings and health sequelae of conditions occurring in this population. She is Chief Investigator on several projects, including the EASY-Health (Enhancing Access to Services for Your Health) Project, funded by the Australian Government NDIS ($2.3 million 2020-2024) and the NHMRC funded grant ($1.5M), Bridge to Better Health, investigating whether specialised support to primary care nurses can improve the health of people with intellectual disability attending their practice. Cathy also led MIDAS' successful application as a lead consortium member for the National Centre of Excellence in Intellectual Disability Health ($22.6M over 4 years; consortium led by UNSW). Cathy is a regular presenter at national and internaitonal conferences, often as an invited speaker. She has served on the committee of the RANZCP Section of Psychiatry of Intellectual Disability for over 10 years, is chair of the Qld Branch of the Section and also serves as Vice-President of the Australian Association of Developmental Disability Medicine (AADDM). In 2020 she was awarded the Mater Research Sister Regis Dunne award for Outstanding Contribution to research relative to opportunity.

Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Jingang Medicine (Aus) Pty Ltd, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He was the inaugural president of the Australian Academy of Health and Medical Sciences, and a member of the Australian National Science and Technology Council. He chairs the Australian Medical Research Advisory Board of the Medical Research Future Fund.

He was recognised as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008, and was elected Fellow of the Royal Society of London in 2012. He was appointed Companion of the Order of Australia in the Queen’s Birthday Honours list in 2013.

Dr Jenny Fung is a senior postdoctoral research fellow and lecturer of pharmacology course at the School of Biomedical Sciences (SBMS), UQ. She is an emerging researcher in the reproductive disease field with experience in molecular biology techniques, genetics, functional genomics, statistical and high-throughput computational skills, ex-vivo and in-vivo models of diseases, as well as industry engagement. In 2013, she was awarded a PhD at UQ and continued post-doctoral research in Professor Grant Montgomery's laboratory at QIMRB and IMB, in the field of genetics and genomics with a focus on functional genomics studies in complex diseases and a special interest in endometriosis. Her research has led to the seminal publication identifying the genetics of gene expression in endometrium and the role of gene regulation underlying endometriosis-related pathogenesis. In 2019, she joined Professor Trent Woodruff’s laboratory at SBMS, UQ to work on immunotherapy development for cancer through funding from Pfizer, where she performed immune cell functional assays and genomics analyses. Dr Fung is in a unique position to perform both the wet and dry lab components of multi-disciplinary research. She is currently co-leading multiple projects, where she is contributing her expertise on genetics and functional genomics on immunology to discover target genes and putative pathways underlying disease progression, with an ultimate goal to develop potential effective drugs for reproductive and brain disorders.

Sebastian is an expert on molecular pharmacology of G protein-coupled receptors (GPCRs - the largest class of cell surface recpetors and major drug targets). His lab has a particular interest in those involved in communication between the gastrointestinal tract and brain (the so-called gut-brain axis). Current foccusses include ghrelin, melanocortin 4, dopamine D2, and cholecystokinin receptors and the lab has also worked on the calcitonin, glucagon-like peptide 1 and other receptors. His lab is interested in answering complelling biological questions relating to physiology and pathophysiology of the gut-brain axis all the way down to the level of the receptor.

Sebastian is from Adelaide and received his BSc(Hons) and PhD. from the University of Adelaide, where he worked on the Aryl Hydrocarbon receptor in the lab of Murray Whitelaw. He then did postdoctoral research on haematopoitic stem cell differentiation in Kelly McNagny’s lab at the Biomedical Research Centre at the University of British Columbia before joining Patrick Sexton to work on G protein-coupled receptors at Monash University .

Sebastian is now an ARC Future Fellow with his own research program in the School of Biomedical Sciences at the University of Queensland. He remains an adjunct member of MIPS DDB as well as CCeMMP.

Sebastian has honours and PhD positions for motivated students who have a strong desire to assume ownership of a project and work independently.

Professor Gabrielli completed his undergraduate education at James Cook University in Townsville and PhD at La Trobe University in Melbourne. After two postdoctoral positions in the USA in the emerging field of cell cycle regulation, he was recruited to establish his own independent research at the Queensland Institute of Medical Research, and then recruited to the Diamantina Institute in 2002, and Mater Research Institute in 2016. He is head of the Smiling for Smiddy Cell Cycle Group.

Research Interests

Mechanisms that regulate cell division, particularly progression into mitosis. These mechanisms are often mutated in cancers and are likely to be major contributors to cancer development. Identifying the genetic mutations that disrupt normal progression and particularly mechanisms, known as checkpoints, provides diagnostic and prognostic opportunities. It also provides potential new targets for chemotherapeutics as drugs targeting defective checkpoints have tumour selective cytotoxic potential.

Research Projects

• Identifying the molecular basis for defective checkpoints in melanoma.
• Targeting defective cell cycle responses to ultraviolet radiation, replication stress and TopoII inhibitors in melanoma, and investigating whether the same defects in other cancer types respond to similar targeting.
• Investigating means of identify very early changes in moles that drive progression to melanoma
• Targeting Aurora kinases in HPV-driven cancers

Marcus Gallagher is an Associate Professor in the Artificial Intelligence Group in the School of Information Technology and Electrical Engineering. His research interests are in artificial intelligence, including optimisation and machine learning. He is particularly interested in understanding the relationship between algorithm performance and problem structure via benchmarking. My work includes cross-disciplinary collaborations and real-world applications of AI techniques.

Dr Gallagher received his BCompSc and GradDipSc from the University of New England, Australia in 1994 and 1995 respectively, and his PhD in 2000 from the University of Queensland, Australia. He also completed a GradCert (Higher Education) in 2010.

Maher Gandhi received his medical degree in the UK in 1989, and then trained as a haematologist, including a Fellowship in malignant haematology at Princess Margaret Cancer Centre, Toronto. He was awarded a PhD in immunology at Cambridge University under Patrick Sissons. He moved to Brisbane and from 2003-2024 worked as a Senior Staff Specialist (Pre-Eminent Status) in the Haematology / Oncology Department of the Princess Alexandra Hospital. He leads his own laboratory group and has established an international reputation studying the tumour immune microenvironment in lymphoma and its manipulation, with continuous NHMRC/MRFF funding since 2005. He was Chair of Laboratory Sciences for the Australasian Leukaemia and Lymphoma Group between 2010-2016, won the prestigious Australian Society of Medical Research Clinical Research Award in 2010 and in 2012 took up the inaugural John McCaffrey Cancer Council of Queensland / Office of Health and Medical Research Clinical Research Fellowship. Between 2011-2014 he was privileged to serve as Chair of the Metro South Human Research Ethics Committee. In 2013 he was appointed Professor of Experimental Haematology, University of Queensland, based at the Translational Research Institute, in 2014 became the inaugural Leukaemia Foundation Chair of Blood Cancer Research at the University of Queensland Frazer Institute, and was appointed Cancer Program Head in 2016. In 2018 he became Executive Director and Director of Clinical Research at Mater Research. He also continues to head the Blood Cancer Research Group, which is based in Mater Research. In 2025 to current, he was appointed Chief Executive Officer of the Translational Research Institute and its manufacturing branch TM@TRI, to serve Queenslanders by transforming health through collaborative research.

Dr Elise Gane graduated with a Bachelor of Physiotherapy (Honours Class I) and a University Medal for academic achievement from The University of Queensland in 2008. She worked as a physiotherapist at the Princess Alexandra Hospital (2009-2013), a quaternary public hospital, treating complex patients across the continuum of care from Intensive Care and post-surgical wards to inpatient rehabilitation and outpatient services. In 2014, Elise commenced her PhD with The University of Queensland, focussed on measuring the musculoskeletal side effects at the neck and shoulder that result from neck dissection surgery for head and neck cancer. Following the awarding of her PhD in early 2018, Elise was employed as a post doctoral researcher at the RECOVER Injury Research Centre (UQ) exploring return to work and social roles after road traffic crash. Since January 2019, Elise has fulfilled the role of Physiotherapy Conjoint Research Fellow between the School of Health and Rehabiltiation Sciences (UQ) and the Princess Alexandra Hospital Physiotherapy Department. In this role, Elise mentors physiotherapists in health service-based research (both qualitative and quantitative) whilst also pursuing her own research interests, including a telehealth cancer exercise program. She teaches a research course in systematic review methodology to students in the Physiotherapy Graduate Entry Masters program.

Elise's areas of research interest include codesign, implementation science, allied health led-models of care, oncology rehabiltiation, lymphoedema, chronic disease, physical activity (particularly in rehabilitation settings, chronic disease, or the workplace), and musculoskeletal health.

Professor Coral Gartner is an international expert in tobacco control policy and the world's leading expert on electronic nicotine delivery systems (or e-cigarettes). She is the Director of the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), an Australian Research Council Future Fellow, and the Chair of the Interdisciplinary Tobacco Endgame Research Network, the country lead Investigator for Australia with the International Tobacco Control Policy Evaluation Project (ITC Project), and a Co-Investigator with the SewAUs Wastewater Epidemiology Project. She is currently the Director of Research at the University of Queensland's School of Public Health, the Regional Editor for Australasia for the BMJ journal, Tobacco Control, after serving as a senior editor from 2012-2018. She is the immediate Past President of the Oceania Chapter of the Society for Research on Nicotine and Tobacco (SRNT-O).

She leads a multidisciplinary research team of international experts (located in Australia, New Zealand, Canada, the USA, England, and the Netherlands) to develop the evidence base for tobacco endgame strategies and to identify the most promising policies that could end the cigarette epidemic in Australia, and beyond. Her research program includes consideration of how these policies could be implemented, while mitigating potential unintended impacts and increasing equity. Her research methods span cohort studies, clinical trials, policy analyses, simulation modelling and mixed methods research.

Professor Gartner joined the University of Queensland in 2006. With undergraduate qualifications in environmental health and a PhD in environmental epidemiology, she completed a postdoctoral fellowship on tobacco control policy and held a NHMRC Career Development Fellowship (2014-2018). In 2019, she led the development of UQ’s flagship cross-faculty postgraduate programs in Environmental Health Sciences.

Professor Gartner has published over 300 academic works, including journal articles, book chapters, and submissions to government inquiries, and has served as an expert witness to a number of government inquiries and consultations. She has also authored articles on tobacco control topics for The Conversation.

Professor Christian Gericke is Clinical Dean and Professor of Medicine at the University of Newcastle, Director of Research and Neurologist at Calvary Mater Newcastle, Honorary Neurologist at the John Hunter Hospital, and Adjunct Professor of Neurology at Fiji National University. He is the Convener of the Specialist Medical Review Council (SMRC), Australian Government, a Member of the Queensland Neurology/Neurosurgery Medical Assessment Tribunal, and regularly acts as an Independent Medical Expert for the Supreme Courts of Queensland, Victoria, New South Wales, South Australia and Western Australia, and the Queensland Coroners Court. He consults privately in Brisbane.

Before this, he was the Clinical Director of Neurology at The Prince Charles Hospital, Professor of Medicine at the University of Queensland, Executive Director of Medical Services, Director of Research and Consultant Neurologist at Cairns Hospital and Adjunct Professor of Medicine and Public Health at James Cook University. He also chaired the Far North Queensland Human Research Ethics Committee (HREC).

From 2013 to 2016, he led the Wesley Research Institute, a non-profit medical research institute based at the Wesley Hospital in Brisbane, as its CEO and Director of Research. In 2016/2017, he spent a sabbatical as Consultant Neurologist with a special interest in Epilepsy at Sheffield Teaching Hospitals NHS Foundation Trust. Since 2013, he has been an Honorary Professor in the School of Public Health at the University of Queensland.

From 2010 to 2012, he was Professor of Public Health and Honorary Consultant Neurologist at Peninsula Medical School, Universities of Exeter and Plymouth and Deputy Director of the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care for the English South West Peninsula (PenCLAHRC).

From 2006 to 2010, he was Professor of Health Policy and Director of the Centre for Health Services Research at the University of Adelaide. He also held various roles for the Australian Commonwealth and State Governments, including as Medical Director for Safety and Quality for the State of Tasmania.

From 2003 to 2006, he was Senior Research Fellow /Associate Professor and Deputy Head of the WHO Collaborating Centre for Health Systems Research and Management at Berlin University of Technology, one of the European Observatory on Health Systems and Policies hubs. He has experience working as a management consultant for McKinsey & Company and as an advisor to the European Commission, WHO, GIZ and the World Bank. His expertise and research interests are in health systems research and health policy, health services research, and the economic evaluation of health interventions. He initiated and directed a new Master's programme in Health Economics and Policy at the University of Adelaide. He is an Editorial Board Member of Frontiers in Neurology, Australian Health Review, Internal Medicine Journal and PLOS ONE.

Prof Gericke studied medicine at the Free University of Berlin and spent one year as a DAAD scholar at Tufts and Harvard Medical Schools in Boston, Massachusetts. He was awarded an M.D. research doctorate (magna cum laude) in cognitive neurology from the Free University of Berlin. After completing clinical specialist training in neurology, epileptology and clinical neurophysiology at the Charite University Hospital in Berlin and the University Hospitals of Strasbourg and Geneva, he studied tropical medicine at the University of Aix-Marseille, obtained an M.P.H. from the University of Cambridge, an M.Sc. in Health Policy, Planning and Financing from the London School of Economics/London School of Hygiene & Tropical Medicine, an MBA from Deakin University, and a higher doctorate (Habilitation) in health systems research from Berlin University of Technology. He also holds an Advanced Diploma in Medical Law from King's Inns School of Law in Dublin and is a Certified Independent Medical Examiner (CIME) with the American Board of Independent Medical Examiners (ABIME).

He is a Fellow of the Royal Australasian College of Physicians (FRACP) in Neurology, the Australasian Faculty of Public Health Medicine (FAFPHM), the Royal College of Physicians of Edinburgh (FRCP Edin), the European Academy of Neurology (FEAN), the American Neurological Association (FANA), the American Academy of Neurology (FAAN) and Associate Fellow of the Royal Australasian College of Medical Administrators (AFRACMA).

He is the Chair of the Australian and New Zealand Association of Neurologists (ANZAN) Therapeutics Committee, Chair of the Ethics Section of the American Academy of Neurology (AAN), and Chair of the Royal Australasian College of Physicians (RACP) Research Committee and a Member of the International League Against Epilepsy (ILAE) Standards and Best Practice Council. He also serves on the Federal Council of the Australian Medical Association (AMA).